- Home
- INDB vs IBRX Comparison
INDB vs IBRX Comparison
Compare INDB & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDB
- IBRX
- Stock Information
- Founded
- INDB 1907
- IBRX 2014
- Country
- INDB United States
- IBRX United States
- Employees
- INDB N/A
- IBRX N/A
- Industry
- INDB Major Banks
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INDB Finance
- IBRX Health Care
- Exchange
- INDB Nasdaq
- IBRX Nasdaq
- Market Cap
- INDB 2.8B
- IBRX 2.4B
- IPO Year
- INDB N/A
- IBRX N/A
- Fundamental
- Price
- INDB $61.06
- IBRX $2.87
- Analyst Decision
- INDB Buy
- IBRX Strong Buy
- Analyst Count
- INDB 4
- IBRX 5
- Target Price
- INDB $69.50
- IBRX $11.40
- AVG Volume (30 Days)
- INDB 268.1K
- IBRX 10.1M
- Earning Date
- INDB 07-17-2025
- IBRX 08-11-2025
- Dividend Yield
- INDB 3.89%
- IBRX N/A
- EPS Growth
- INDB N/A
- IBRX N/A
- EPS
- INDB 4.44
- IBRX N/A
- Revenue
- INDB $654,155,000.00
- IBRX $31,222,000.00
- Revenue This Year
- INDB $27.60
- IBRX $567.98
- Revenue Next Year
- INDB $25.32
- IBRX $160.56
- P/E Ratio
- INDB $13.67
- IBRX N/A
- Revenue Growth
- INDB N/A
- IBRX 10238.41
- 52 Week Low
- INDB $45.11
- IBRX $1.83
- 52 Week High
- INDB $77.23
- IBRX $7.63
- Technical
- Relative Strength Index (RSI)
- INDB 43.25
- IBRX 49.40
- Support Level
- INDB $60.25
- IBRX $2.77
- Resistance Level
- INDB $70.00
- IBRX $3.24
- Average True Range (ATR)
- INDB 1.86
- IBRX 0.23
- MACD
- INDB -0.35
- IBRX -0.03
- Stochastic Oscillator
- INDB 9.61
- IBRX 19.74
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.